Keyphrases
Neuroblastoma
84%
Human Pluripotent Stem Cells (hPSCs)
84%
Germ Cell Tumor
69%
RAS-MAPK Pathway
56%
Genetic Aberrations
53%
Aberrations
52%
Tumor
50%
Tumor Protein p53 (TP53)
42%
MEK Inhibitor (MEKi)
40%
Therapeutic Vulnerabilities
39%
Cell-based
38%
Pluripotent
38%
Oncogene
38%
Mediastinal Germ Cell Tumor
35%
Cisplatin Resistance
35%
RAS-MAPK
35%
Bcl-2 Family
35%
Feeder-free Culture
35%
Chromosome 1q
35%
Safety Issues
35%
Murine Double Minute 4 (MDM4)
35%
Tumor Risk
35%
Cell Population
35%
MCM9
35%
Low Amplitude
35%
Copy number Gain
35%
Epigenetics
31%
Malignant Germ Cell Tumors
29%
Trametinib
28%
Refractory Neuroblastoma
27%
Tumor Subtype
26%
Pluripotent Stem Cells
25%
Teratoma
23%
Human Germ Cells
22%
Chromosome 11q
22%
Selective Advantage
21%
Stem Cell-derived
20%
Cas9 Protein
20%
Neuroblastoma Cell Line
18%
Pathway mutation
17%
Loss Amplification
17%
Large Deletion
17%
Chromosomal Deletion
17%
Germ Cell Malignancy
17%
Tumor Progression
17%
Targeted Drugs
17%
Somatic Malignancy
17%
Checkpoint Kinase 1 (CHK1)
17%
Pediatric Cancer
17%
MYCN Amplification
17%
Medicine and Dentistry
Germinoma
100%
Neoplasm
76%
Pluripotent Stem Cell
71%
Cisplatin
41%
Tumor
41%
Stem Cell Therapy
40%
Cancer
39%
Ganglioneuroblastoma
35%
Cell Population
35%
Yolk Sac
35%
Malignant Neoplasm
25%
Mediastinal Germ Cell Tumor
25%
Disease
23%
Human Pluripotent Stem Cell
20%
Mitogen-Activated Protein Kinase
17%
Checkpoint Kinase 1
17%
Chromosome 11q
17%
Recurrent Disease
17%
Lethality
17%
Pediatric Cancer
17%
Somatics
17%
Carcinogenesis
14%
Dentigerous Cyst
13%
Endodermal Sinus Tumor
12%
Infancy
10%
Diabetes Mellitus
10%
Medicine
10%
Malignant Transformation
10%
Primary Tumor
10%
Diseases
9%
Diagnosis
8%
Heat Map
8%
Pediatrics
8%
Biological Marker
8%
Solid Malignant Neoplasm
8%
Protein P53
7%
Chemotherapy
6%
Leiomyosarcoma
6%
In Vitro
6%
Treatment Option
5%
Minimal Residual Disease
5%
microRNA
5%
Chromosome 3p
5%
Genetic Screening
5%
Translational Research
5%
Testis Cancer
5%
Overall Survival
5%
Knock Out
5%
Embryonal Carcinoma
5%
Clinical Trial
5%
Biochemistry, Genetics and Molecular Biology
Stem Cell
99%
Germ Cell
59%
Genetics
52%
Stem Cell Transplantation
41%
Cisplatin
35%
Mitogen-Activated Protein Kinase
35%
Chromosome 1q
35%
MDM4
35%
Oncogene
35%
Chromosome 11q
26%
Teratoma
25%
CRISPR/Cas9
20%
Chromosomal Aberration
20%
Genomics
19%
Neuroendocrine Cell
17%
Kinase
17%
Phosphotransferase
17%
Tumor Progression
17%
Vitronectin
17%
Germline
17%
Aneuploidy
17%
Embryonic Stem Cell
17%
Carcinogenesis
14%
Synteny
14%
P53
13%
Autosome
12%
Chromosome 6
10%
Trisomy
10%
DNA Repair
10%
Directed Differentiation
10%
Malignant Transformation
10%
Infancy
10%
Human Chorionic Gonadotropin
8%
Polyploid
8%
Clonal Variation
8%
Tumor Marker
8%
Clonality
8%
Alpha-Fetoprotein
8%
DNA Methylation
8%
Growth, Development and Aging
8%
Functional Genomics
8%
Chromosome 6q
8%
Colony Forming Unit S
8%
RNA Sequence
8%
Adolescence
8%
Karyotyping
8%
Stem Cell Culture
8%
Prevalence
8%
Deficiency
8%
Overall Survival
7%
